XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.3
ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jan. 23, 2024
Jun. 15, 2023
Apr. 30, 2023
Mar. 17, 2023
Feb. 28, 2023
Sep. 30, 2024
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Jan. 06, 2023
Dec. 19, 2018
VAT net receivable and payable balance           $ 322,576     $ 322,576   $ 187,512    
Long-term liability           395,698     395,698   408,665    
Allowance for doubtful accounts                 19,905,776   19,686,091    
Deferred amount                     397,000    
Foreign accounts           12,655,615     12,655,615   532,704    
Depreciation expense           89,694   $ 124,910 306,126 $ 237,479      
Amortization expense           196,183   $ 88,168 579,556 $ 138,438      
Equity method investment aggregate cost                       $ 3,950,000  
Goodwill           49,697     49,697   $ 49,697   $ 49,697
ICC International Cannabis Corp [Member]                          
Equity method investment aggregate cost           0     $ 0        
National Bank of Greece [Member]                          
Shares of common stock issued                 16,666        
Equity method investment aggregate cost           12,416     $ 12,416        
Closing price                 $ 0.75        
Pancreta Bank [Member]                          
Equity method investment aggregate cost           $ 7,665     $ 7,665        
Greece [Member]                          
Cash   $ 109,330                      
Intangible assets   425,411                      
Issuable stock amount   $ 316,081                      
Income tax rate                 22.00%        
Shares issued   99,710                      
United Kingdom Of England [Member]                          
Income tax rate                 25.00%        
CANA Pharmaceutical Laboratories, S.A. ("Cana") [Member]                          
Cash             $ 873,600            
Issuable stock amount             $ 138,667   $ 138,667        
Shares issued             46,377            
Asset acquision         $ 5,469,787                
Secured Promissory Note         $ 4,457,520                
Zip Doctor Inc [Member]                          
Cash       $ 150,000                  
Payment in fees       $ 8,788                  
Cloudscreen [Member]                          
Cash $ 317,880   $ 1,054,872                    
Total purchase price amount $ 637,080                        
Shares of common stock issued 280,000                        
Shares of common fair value $ 319,200                        
Asset acquisition $ 637,080